regulatory
confidence high
sentiment negative
materiality 0.70
CHARLES & COLVARD LTD: Nasdaq/NYSE listing notice — Charles & Colvard receives Nasdaq bid price deficiency notice; 180-day cure period
CHARLES & COLVARD LTD
- Nasdaq notified CTHR on June 12, 2023 that bid price closed below $1.00 for 30 consecutive business days.
- Company has until December 11, 2023 to regain compliance: bid price must close at $1.00+ for 10 consecutive days.
- If compliance not met, Nasdaq may grant an additional 180-day period if other listing standards are met.
- Failure to cure could lead to delisting; company may appeal any such determination.
- Management will monitor bid price and consider options to regain compliance.